Abstract
PurposeThe first aim of the trial is to study feasibility of combined programmed death protein ligand 1/cytotoxic T-lymphocyte-associated protein 4 inhibition concomitant to radiotherapy. In addition, efficacy of the entire...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have